Congratulations to our brilliant scientist, Tobias Suske, on publishing his PhD study in the high-impact Journal of Clinical Investigation (JCI)!
In this paper, Tobias explored molecular mechanisms of how mutated hyperactive STAT5 causes T cell acute lymphoblastic leukemia (T-ALL). His work sheds light on the mechanisms underlying this disease and validates STAT5 as a key target in T-ALL and cancer.
We couldn’t be prouder to have him as part of our team, driving innovation and pushing scientific discovery’s boundaries.
Article: J Clin Invest. 2024;134(8):e168536. https://doi.org/10.1172/JCI168536.
RIANA Therapeutics 